Literature DB >> 11462071

Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy.

R M Barraclough1, A J Gillies.   

Abstract

Pulmonary alveolar proteinosis is a rare condition traditionally requiring treatment with whole lung lavage. The case is presented of a young man who obtained complete remission following treatment with granulocyte-macrophage colony stimulating factor, a new treatment option.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11462071      PMCID： PMC1746117          DOI： 10.1136/thorax.56.8.664

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  4 in total

1.  Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.

Authors:  P Latzin; M Tredano; Y Wüst; J de Blic; T Nicolai; B Bewig; F Stanzel; D Köhler; M Bahuau; M Griese
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  Temporary remission of autoimmune pulmonary alveolar proteinosis after infectious episodes.

Authors:  Takehiko Kobayashi; Toru Arai; Masaki Hirose; Tomomi Homma; Akiko Matsumuro; Chikatoshi Sugimoto; Masanori Kitaichi; Masanori Akira; Yoshikazu Inoue
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Pulmonary alveolar proteinosis: a case report and world literature review.

Authors:  Armando J Huaringa; Wassem H Francis
Journal:  Respirol Case Rep       Date:  2016-11-13

4.  Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis.

Authors:  Kamal Sewaralthahab; Helmut Rennke; Sarah Sewaralthahab; Nicolaos E Madias; Bertrand L Jaber
Journal:  Clin Nephrol Case Stud       Date:  2014-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.